The Wedensky test predicts malignant ventricular arrhythmias after myocardial infarction

References

• Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med. 2003;138:445–52.
   PubMed Web of Science ®Google Scholar
• Moss AJ, Hall WJ, Cannom DS, Debaurt JP, Higgins SL, Klein H, et al. (for the Multicenter Automatic Defibrillator Implantation Trial (MADIT) Investigators). Improved survival with an implantable defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933–40.
   PubMed Web of Science ®Google Scholar
• Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. (for the MADIT II Investigators). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–83.
   PubMed Web of Science ®Google Scholar
• Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G, (for the Multicenter Unsustained Tachycardia Trial (MUSST) Investigators). A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J.Med. 1999;341: 1882–90.
   PubMed Web of Science ®Google Scholar
• Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. (for Practice Guidelines Writing Committee). ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol 2006;48:E247–E346.
   PubMedGoogle Scholar
• Amlie JP, Olsson SB. Should we implant ICDs in more patients after myocardial infarction? Can we define the patient groups that benefits most? Scand Cardiovasc J. 2002;36:259–6.
   PubMed Web of Science ®Google Scholar
• Buxton AE, Lee KL, Hafley GE, Pires LA, Fisher JD, Gold MR, et al. (for the MUSTT Investigators). Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol. 2007;50:1150–7.
   PubMed Web of Science ®Google Scholar
• Passman R, Kadish A. Sudden death prevention with implantable devices. Circulation 2007;116:561–71.
   PubMed Web of Science ®Google Scholar
• Chow T, Kereiakes DJ, Onufer J, Woelfel A, Gursoy S, Peterson BJ, et al. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? J Am Coll Cardiol. 2008;52:1607–15.
   PubMed Web of Science ®Google Scholar
• Haugaa KH, Smedsrud MK, Steen T, Kongsgaard E, Loennechen JP, Skjaerpe T, et al. Mechanical dispersion assessed by myocardial strain in patients after myocardial infarction for risk prediction of ventricular arrhythmia. JACC Cardiovasc Imaging. 2010;3:247–56.
   PubMed Web of Science ®Google Scholar
• Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, et al. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet. 1999;353:1390–6.
   PubMed Web of Science ®Google Scholar
• Bauer A, Kantelhardt JW, Barthel P, Schneider R, Mäkikallio T, Ulm K, et al. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: Cohort study. Lancet. 2006;367:1674–81.
   PubMed Web of Science ®Google Scholar
• Exner DV, Kavanagh KM, Slawnych MP, Mitchell LB, Ramadan D, Aggarwal SG, et al. (for the REFINE Investigators). Noninvasive risk assessment early after a myocardial infarction: the REFINE study. J Am Coll Cardiol. 2007; 50:2275–84.
   PubMed Web of Science ®Google Scholar
• Breithardt G, Cain ME, el-Sharif N, Hombach V, Janse M, Somson MB, et al. Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography: A statement by a task force committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. Circulation. 1991;83:1481–8.
   PubMed Web of Science ®Google Scholar
• Hnatkova K, Malik M. Noninvasive Wedensky modulation. Card Electrophysiol Rev. 1999;3:269–73.
   Google Scholar
• Hnatkova K, Ryan SJ, Bathen J, Hoium HH, Malik M. Non-invasive Wedensky modulation within the QRS complex. Med Biol Eng Comput. 2002;40:234–40.
   PubMed Web of Science ®Google Scholar
• Malik M, Hnatkova K, Batchvarov VN. Post infarction risk stratification using the 3-D angle between QRS complex and T-wave vectoracutes. J Electrocardiol. 2004;37:P201–8.
   PubMed Web of Science ®Google Scholar
• Elgarhi N, Kreuz J, Balta O, Nickenig G, Hoium H, Lewalter T, Schwab JO. Significance of Wedensky Modulation testing in the evaluation of non-invasive risk stratification for ventricular tachyarrhythmia in patients with coronary artery disease and implantable cardioverter-defibrillator. Heart. 2008;94:e16.
   PubMedGoogle Scholar
• Wedensky NE. Die Erregung, Hemmung und narkose. Pflügers Arch. 1903;100:1–9.
   Google Scholar
• Castellanos A, Lemberg L, Johnson D, Berkovits BV. The Wedensky effect in the human heart. Br Heart J. 1966; 28:276–283.
   PubMedGoogle Scholar
• Myerburg RJ, Reddy V, Castellanos A. Indications for Implantable Cardioverter-Defibrillators based on evidence and judgment. J Am Coll Cardiol. 2010;54:747–63.
   Web of Science ®Google Scholar
• Erikssen G, Liestøl K, Gullestad L, Haugaa KH, Bendz B, Amlie JP. The terminal part of the QRS complex (peak T to end T) is a predictor for mortality after acute myocardial infarction. Ann Noninvasively Electrocardiol. 2012;17:85–94.
   PubMed Web of Science ®Google Scholar